Chinese pharma app seals $133m series D funding

Pharmaceutical trading platforms like Yaoshibang help stores in dispersed and remote cities to meet the increasing demand of patients.

Carol Huang

December 17, 2018

Chinese B2B pharmaceutical trading platform Yaoshibang has completed its $133 million Series D fundraising on Monday.

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].